Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

被引：18

作者：

Berenguer, Marina ^{[2
,3
]}

Charco, Ramon ^{[4
]}

Manuel Pascasio, Juan ^{[5
]}

Ignacio Herrero, Jose ^{[1
,2
]}

机构：

[1] Univ Navarra Clin, Liver Unit, Pamplona 31008, Spain

[2] CIBERehd, Valencia, Spain

[3] Hosp La Fe, Hepatol Unit, E-46009 Valencia, Spain

[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, HBP Surg & Transplant Dept, E-08193 Barcelona, Spain

[5] Hosp Virgen del Rocio, Dept Digest Dis, Seville, Spain

来源：

LIVER INTERNATIONAL | 2012年 / 32卷 / 05期

关键词：

donor; immunosuppression; recurrence; survival; treatment; SUSTAINED VIROLOGICAL RESPONSE; CORTICOSTEROID-FREE IMMUNOSUPPRESSION; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; RABBIT ANTITHYMOCYTE GLOBULIN; PREEMPTIVE ANTIVIRAL THERAPY; PROSPECTIVE RANDOMIZED-TRIAL; RAPID-FIBROSIS-PROGRESSION; VENOUS-PRESSURE GRADIENT; RECURRENT HEPATITIS; PEGYLATED-INTERFERON;

D O I：

10.1111/j.1478-3231.2011.02731.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In November 2010, the Spanish Society of Liver Transplantation (Sociedad Espanola de Trasplante Hepatico, SETH) held a consensus conference. One of the topics of debate was liver transplantation in patients with hepatitis C. This document reviews (i) the natural history of post-transplant hepatitis C, (ii) factors associated with post-transplant prognosis in patients with hepatitis C, (iii) the role of immunosuppression in the evolution of recurrent hepatitis C and response to antiviral therapy, (iv) antiviral therapy, both before and after transplantation, (v) follow-up of patients with recurrent hepatitis C and (vi) the role of retransplantation.

引用

页码：712 / 731

页数：20

共 219 条

[1] Evolution of liver transplantation in Europe: Report of the European liver transplant registry [J].

Adam, P ;

McMaster, P ;

O'Grady, JG ;

Castaing, D ;

Klempnauer, JL ;

Jamieson, N ;

Neuhaus, P ;

Lerut, J ;

Salizzoni, M ;

Pollard, S ;

Muhlbacher, F ;

Rogiers, X ;

Valdecasas, JCG ;

Berenguer, J ;

Jaeck, D ;

Gonzalez, EM .

LIVER TRANSPLANTATION, 2003, 9 (12) :1231-1243

[2] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin [J].

Al-Hamoudi, Waleed ;

Mohamed, Hazem ;

Abaalkhail, Faisal ;

Kamel, Yaser ;

Al-Masri, Nasser ;

Allam, Naglaa ;

Alqahtani, Saleh ;

Al-Sofayan, Mohammed ;

Khalaf, Hatem ;

Al-Sebayel, Mohammed ;

Al-Jedai, Ahmed ;

Abdo, Ayman .

DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) :1848-1852

[3] Post-liver transplantation diabetes mellitus: An association with hepatitis C [J].

AlDosary, AA ;

Ramji, AS ;

Elliott, TG ;

Sirrs, SM ;

Thompson, DM ;

Erb, SR ;

Steinbrecher, UP ;

Yoshida, EM .

LIVER TRANSPLANTATION, 2002, 8 (04) :356-361

[4] A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C [J].

Angelico, Mario ;

Petrolati, Alessandra ;

Lionetti, Raffaella ;

Lenci, Ilaria ;

Burra, Patrizia ;

Donato, Maria Francesca ;

Merli, Manuela ;

Strazzabosco, Mario ;

Tisone, Giuseppe .

JOURNAL OF HEPATOLOGY, 2007, 46 (06) :1009-1017

[5] The use of hepatitis C-infected grafts in liver transplantation [J].

Arenas, JI ;

Vargas, HE ;

Rakela, J .

LIVER TRANSPLANTATION, 2003, 9 (11) :S48-S51

[6] The impact of sirolimus on hepatitis C recurrence after liver transplantation [J].

Asthana, Sonal ;

Toso, Christian ;

Meeberg, Glenda ;

Bigam, David L. ;

Mason, Andrew ;

Shapiro, A. M. James ;

Kneteman, Norman M. .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 25 (01) :28-34

[7] Decision for retransplantation of the liver - An experience- and cost-based analysis [J].

Azoulay, D ;

Linhares, MM ;

Huguet, E ;

Delvart, V ;

Castaing, D ;

Adam, R ;

Ichai, P ;

Saliba, F ;

Lemoine, A ;

Samuel, D ;

Bismuth, H .

ANNALS OF SURGERY, 2002, 236 (06) :713-721

[8] Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy [J].

Babatin, M ;

Schindel, L ;

Burak, KW .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (06) :359-365

[9] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[10] Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality [J].

Baid, S ;

Cosimi, AB ;

Farrell, ML ;

Schoenfeld, DA ;

Feng, S ;

Chung, RT ;

Tolkoff-Rubin, N ;

Pascual, M .

TRANSPLANTATION, 2001, 72 (06) :1066-1072

← 1 2 3 4 5 6 7 8 9 10 →